Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000726910 | SCV000523330 | likely benign | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080913 | SCV000636221 | likely benign | Charcot-Marie-Tooth disease, type I | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726910 | SCV000704126 | uncertain significance | not provided | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726910 | SCV001151224 | likely benign | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173926 | SCV001337045 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002323607 | SCV002609201 | likely benign | Inborn genetic diseases | 2020-08-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |